Patterns of prostate-specific antigen (PSA) testing in Australian men: the influence of family history

被引:12
作者
McDowell, Michelle E. [1 ]
Occhipinti, Stefano [1 ]
Gardiner, Robert A. [2 ,3 ]
Chambers, Suzanne K. [2 ]
机构
[1] Griffith Univ, Sch Appl Psychol, Griffith Hlth Inst, Mt Gravatt, Qld 4111, Australia
[2] Univ Queensland, Clin Res Ctr, Brisbane, Qld 4072, Australia
[3] Royal Brisbane Hosp, Dept Urol, Brisbane, Qld, Australia
关键词
prostate cancer; family history; early detection; CANCER; RELATIVES; RISK; METAANALYSIS;
D O I
10.1111/j.1464-410X.2012.11050.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To describe how a family history of prostate cancer influences men's prostate cancer testing behaviours, information support preferences, and motives for testing. SUBJECTS AND METHODS Men with a fi rst-degree family history (239 men) and a comparison sample from the general population of Queensland, Australia (289) aged 40-65 years, and no prior history of cancer. Cross-sectional, retrospective survey assessing: prevalence of prostate-specifi c antigen (PSA) testing and digital rectal examination (DRE); discussion of prostate cancer risks and benefi ts with a physician; prostate cancer information needs and preferences; motivations for testing. RESULTS Men with a family history were more likely to report: having ever had a PSA test (odds ratio [OR] 4.98; 95% confi dence interval [CI] 3.16-7.85), more PSA tests in their lifetimes (b 1.04; SE 0.40; 95% CI 0.26-1.82); to have had a DRE (OR 2.23; 95% CI 1.54-3.23); to have spoken to a doctor about prostate cancer (OR 3.72; 95% CI 2.30-6.02); and to have instigated these discussions (OR 1.74; 95% CI 1.13-2.70). Most men from both groups did not recall any discussion of the ` cons ' of prostate cancer testing with a doctor. Men with a family history reported a greater desire for information about prostate cancer prevention than did men without a family history. CONCLUSIONS Men with a family history are more concerned about getting prostate cancer and are tested more often; however, information needs, discussions about prostate cancer, and motivations for testing are similar to those of all men. There appears to be a disparity between public health approaches that promote informed decision-making and what is happening in practice.
引用
收藏
页码:64 / 70
页数:7
相关论文
共 50 条
  • [11] The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence declinein the United States
    Julie M. Legler
    Eric J. Feuer
    Arnold L. Potosky
    Ray M. Merrill
    Barnett S. Kramer
    Cancer Causes & Control, 1998, 9 : 519 - 527
  • [12] The Dilemma of Prostate-Specific Antigen Testing
    Leach, Robin
    Thompson, Ian M.
    ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (11) : 835 - 836
  • [13] PSA Quo Vadis? It Is Reasonable to Start with Prostate-Specific Antigen Testing at the Age of 40!
    Boergermann, Christof
    vom Dorp, Frank
    Swoboda, Andreas
    Ketteniss, Oskar
    Becker, Markus
    Ruebben, Herbert
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (06) : 1190 - 1195
  • [14] Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
    Liu, Xin
    Tang, Jie
    Fei, Xiang
    Li, Qiu-Yang
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2015, 44 (11) : 1466 - 1472
  • [15] The use of prostate-specific antigen testing in men presenting with haematuria
    Bromage, Stephen J.
    Napier-Hemy, Richard D.
    Payne, Stephen R.
    Pearce, Ian
    McIntyre, Iain G.
    BJU INTERNATIONAL, 2006, 98 (06) : 1221 - 1224
  • [16] Prostate-specific antigen (PSA): A tumor marker in the diagnosis of prostate cancer
    Ohlendorf D.
    Wanke E.M.
    Braun M.
    Oremek G.M.
    Groneberg D.A.
    Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie, 2017, 67 (4) : 221 - 223
  • [17] Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer
    Iyer, Hari S.
    Stone, Benjamin V.
    Roscoe, Charlotte
    Hsieh, Mei-Chin
    Stroup, Antoinette M.
    Wiggins, Charles L.
    Schumacher, Fredrick R.
    Gomez, Scarlett L.
    Rebbeck, Timothy R.
    Trinh, Quoc-Dien
    JAMA NETWORK OPEN, 2024, 7 (06)
  • [18] Lifestyle factors and prostate-specific antigen (PSA) testing in UK Biobank: Implications for epidemiological research
    Littlejohns, Thomas J.
    Travis, Ruth C.
    Key, Tim J.
    Allen, Naomi E.
    CANCER EPIDEMIOLOGY, 2016, 45 : 40 - 46
  • [19] Does obesity affect the accuracy of prostate-specific antigen (PSA) for predicting prostate cancer among men undergoing prostate biopsy
    Oh, Jong J.
    Jeong, Seong J.
    Lee, Byung K.
    Jeong, Chang W.
    Byun, Seok-Soo
    Hong, Sung K.
    Lee, Sang E.
    BJU INTERNATIONAL, 2013, 112 (04) : E265 - E271
  • [20] Classifying the Reasons Men Consider to be Important in Prostate-Specific Antigen (PSA) Testing Decisions: Evaluating Risks, Lay Beliefs, and Informed Decisions
    McDowell, Michelle E.
    Occhipinti, Stefano
    Chambers, Suzanne K.
    ANNALS OF BEHAVIORAL MEDICINE, 2013, 46 (03) : 322 - 335